With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.
Looking for a particular MaSTherCell employee's phone or email?
MaSTherCell Questions
The MaSTherCell annual revenue was $4.4 billion in 2026.
9 people are employed at MaSTherCell.
MaSTherCell is based in Gosselies, Wallonia.
The NAICS codes for MaSTherCell are [54, 5417, 541].
The SIC codes for MaSTherCell are [283, 28].
Top MaSTherCell Employees
-
Daxx Garman
Head Of Supply Chain Management at MaSTherCell
Houston, TX, US32 -
Anne-Cécile Pay
Qc Specialist at MaSTherCell
Sombreffe, BE -
Assena Konk
Qc Specialist at MaSTherCell
Eghezee, WAL, BE -
Nicolas Markadieu
Analytical Development Expert Qc at MaSTherCell
Brussels, Belgium3 -
Jessica Laitem
Assurance qualité at MaSTherCell
Mons, Wallonia, BE1 -
Sacha Camusot
Cell culture specialist at MaSTherCell
Charleroi, WAL, BE
Related Companies
